Jean-François Martini Selected Research

Hypercholesterolemia

5/2023

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-François Martini Research Topics

Disease

11	Neoplasms (Cancer) 11/2023 - 03/2015
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 01/2016
7	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 01/2016
2	Neoplasm Metastasis (Metastasis) 12/2018 - 12/2017
1	Disease Progression 05/2023
1	Brain Neoplasms (Brain Tumor) 05/2023
1	Hypertriglyceridemia 05/2023
1	Edema (Dropsy) 05/2023
1	Hypercholesterolemia 05/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022
1	Adenocarcinoma 11/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Fatigue 03/2015
1	Exanthema (Rash) 03/2015
1	Diarrhea 03/2015

Drug/Important Bio-Agent (IBA)

6	lorlatinibIBA 05/2023 - 12/2017
5	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2016
5	Sunitinib (Sutent)FDA Link 02/2021 - 01/2016
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 12/2017
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2016
3	CrizotinibIBA 05/2023 - 01/2016
2	palbociclibIBA 11/2022 - 01/2021
2	Axitinib (AG 013736)IBA 04/2021 - 11/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2019
1	Circulating Tumor DNAIBA 11/2023
1	cyclo(Arg-Pro) (CI 4)IBA 05/2023
1	Drug CombinationsIBA 11/2022
1	130-nm albumin-bound paclitaxelIBA 11/2022
1	c-Mer Tyrosine KinaseIBA 10/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022
1	CytokinesIBA 01/2022
1	Everolimus FDA Link 04/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	PlatinumIBA 01/2021
1	pembrolizumabIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017
1	dacomitinibIBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 06/2015
1	TabletsIBA 03/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2015
1	XL147IBA 03/2015

Therapy/Procedure

6	Therapeutics 10/2022 - 12/2017
1	Nephrectomy 10/2022
1	Precision Medicine 01/2019